The global burden of childhood bacterial meningitis is substantial. A
systematic review of 36 studies from the world’s developing nations estimated
that there are 126 000 cases of neonatal meningitis annually, with over 50 000
deaths. In these countries the major neonatal pathogens are Gram negative
bacilli, such as Escherichia coli and Klebsiella species. A
further recent review of almost 30 000 children and adults in 50 studies from 25
African countries found Streptococcus pneumoniae and
type b to be the commonest causes of bacterial meningitis, with Neisseria
meningitidis ranked third. Annually there are 400 000 cases alone of H
influenzae b meningitis in the developing world: 80% are in infants, nearly
30% die, and another 30% have major impairments. Experience in the developed
world suggests that even if mortality can be greatly reduced, the burden of
continuing morbidity from meningitis in infancy remains high.
After the introduction of conjugate H influenzae b
vaccines the United States has seen a 73% reduction in the incidence of
paediatric bacterial meningitis, with fewer than 3000 cases each year. A
meta-analysis of 1602 prospectively enrolled children with bacterial meningitis
from 19 studies in Europe and North America found that 4.5% died, but at least
one major adverse outcome was present (severe intellectual disability, spasticity, paresis, seizures, deafness) in 16.4% of survivors.
There are few reports of the long term complications of
bacterial meningitis. A Canadian study of 97 survivors of H incluenzae b
meningitis identified by chart review found that those suffering acute
neurological complications (seizures, coma, focal neurological deficits, hearing
loss) had poorer school performance and more behaviour difficulties than their
siblings.
These findings were extended by a prospective cohort study
from Melbourne, where 130 school aged children were assessed seven and 12 years
after meningitis. Though they achieved average scores on measures of
intelligence, learning, and high level neuropsychological skills, after
adjusting for socio-demographic variables these scores were consistently below
those of age and grade matched controls. Only 53% of children experiencing acute
neurological complications were judged as normal, while those presenting during
infancy performed especially poorly on language and reading measures and complex
learning tasks. There were also increased behaviour problems over time, possibly
from academic difficulties and low self-esteem.
Twelve years after meningitis, 38% of patients had either
major neurological, auditory, or intellectual impairments or functionally
important behaviour or learning disorders impeding their academic performance.
In comparison, 11% of controls had minor functional disabilities. Similar
findings of cognitive and behaviour impairment have recently been observed in
another prospective cohort study in which 115 survivors of meningococcal disease
from Liverpool were compared 10 years after their illness with age and sex
matched controls.
A questionnaire survey of parents and general practitioners
about 1717 children aged 5 years who had had meningitis during infancy, was
undertaken together with matched controls. The children were originally
identified by a prospective national study of infantile meningitis in England
and Wales in 1985-7.
Those who had had meningitis were at significantly greater
risk of disability across all health, developmental and behavioural categories
tested, but especially in the domains of learning and neuro-motor function. At
greatest risk were neonates and those infected by S pneumoniae and their
original illness had died by the age of 5 and at least half of these deaths
seemed attributable to complications of meningitis.
The strengths of this study include its prospective design,
recruitment restricted to infants within a national population base, large
numbers affected by different pathogens, and high retention rates. This provides
future opportunities for comprehensive neuro-psychometric assessments during
school years and into adolescent and adulthood.
Outcomes that may be clarified include the long term complications of
neonatal meningitis, effects of pathogens other than H influenzae b, and
whether higher cognitive functions, like some lower order skills, improve with
maturation. This should also help in understanding critical phases of postnatal
brain development